Your browser doesn't support javascript.
loading
Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Mondal, Tanmoy; Gaur, Himanshu; Wamba, Brice E N; Michalak, Abby Grace; Stout, Camryn; Watson, Matthew R; Aleixo, Sophia L; Singh, Arjun; Condello, Salvatore; Faller, Roland; Leiserowitz, Gary Scott; Bhatnagar, Sanchita; Tushir-Singh, Jogender.
Afiliação
  • Mondal T; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
  • Gaur H; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Wamba BEN; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
  • Michalak AG; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Stout C; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
  • Watson MR; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Aleixo SL; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
  • Singh A; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Condello S; Undergraduate Research Program Volunteers, University of California Davis, Davis, CA, USA.
  • Faller R; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
  • Leiserowitz GS; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.
  • Bhatnagar S; Undergraduate Research Program Volunteers, University of California Davis, Davis, CA, USA.
  • Tushir-Singh J; Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
Cell Death Differ ; 30(11): 2408-2431, 2023 11.
Article em En | MEDLINE | ID: mdl-37838774

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Antígenos Quiméricos Limite: Female / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Antígenos Quiméricos Limite: Female / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos